Live
Krsnaa Diagnostics (KDL) made a decent debut on the bourses, with the company’s shares getting listed at Rs 1,025, a 7.4 per cent premium against the issue price of Rs 954 per share on the BSE. On the National Stock Exchange (NSE), the stock of the healthcare services company opened at Rs 1,006, a 5.5 per cent higher against its issue price.
In the morning trade, the stock quoted at Rs 1,085.45, up 14 per cent higher than the issue price. It hit a high of Rs 1,099.50 and a low of Rs 961.45 on the BSE so far. A combined 3.6 million equity shares changed hands on the counter on the NSE and BSE.
- Andhra Pradesh Approves Rs 500 Crore Port, Shipbuilding Cluster
- Amazon Eyes Faster Content Production With AI
- Why India Is Emerging as a Second Home for Multinationals
- Indigo Shares Slip 2% as CCI Orders Further Investigation
- Concord Control Wins KAVACH 4.0 Order; Stock Jumps 4%
The initial public offer (IPO) of KDL got a strong response from the investors as the issue got subscribed 64.38 times. The qualified institutional buyers (QIBs) portion was subscribed 49.83 times, the non-institutional investors (NII) or wealthy investor portion was subscribed 116.30 times, and the retail amount was subscribed 41.95 times.
Stock Covered in the news
